CIK: 1271411 - Address: C/o Imara, Inc., 116 Huntington Avenue, 6Th Floor, Boston, MA 02116
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret11622-8-11-19-18-9
S%wins6733836710010075

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/22/23 20:26
2/22/23
IMRAImara Inc.DEHealthDrugPharmaceutical PreparationsGray MichaelMAOCFO,COOS-464.670-10-2628D
2/1/23 18:26
1/30/23
IMRAImara Inc.DEHealthDrugPharmaceutical PreparationsGray MichaelMAOCFO,COOS-143.920-4-937D
12/15/20 16:26
12/11/20
IMRAImara Inc.DEHealthDrugPharmaceutical PreparationsGray MichaelMAOCFO,COOS.d-3125.000-1-1000D
9/21/12 16:04
9/18/12
CRISCuris IncDEHealthBioPrdBiological Products, (No DiagGray MichaelMAOCOO,CFOS.d-1124.282-26-2387D21642-7-14-2-212-1-3-7-15-22-1
4/20/12 16:57
4/18/12
CRISCuris IncDEHealthBioPrdBiological Products, (No DiagGray MichaelMAOCOO,CFOS.dm-2155.013-43-3387D47183617-390-3-1-107-15-37
1/12/05 10:26
1/10/05
CRISCuris IncDEHealthBioPrdBiological Products, (No DiagGray MichaelMAOCFOS.d-464.622-10-1000D361-10272615-16-11-401-10-18-3-14
12/10/04 16:11
12/8/04
CRISCuris IncDEHealthBioPrdBiological Products, (No DiagGray MichaelMAOCFOS.d-504.973-10-1000D342-31714302423-549-5-25-28-26
12/6/04 09:28
12/2/04
CRISCuris IncDEHealthBioPrdBiological Products, (No DiagGray MichaelMAOCFOS.d-824.512-18-1000D385-8213482119191031-21-25-21
9/14/04 14:18
9/13/04
CRISCuris IncDEHealthBioPrdBiological Products, (No DiagGray MichaelMAOCFOS.d-514.551-11-1000D5725-104462010601-199-19-6

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact